felodipine has been researched along with Cardiomyopathies in 1 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Felodipine pretreatment was able to maintain normal cardiac morphology and histoarchitecture." | 1.39 | Doxorubicin mediated cardiotoxicity in rats: protective role of felodipine on cardiac indices. ( Balaraman, R; Gandhi, H; Mistry, N; Nandania, J; Patel, VB; Patni, N, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gandhi, H | 1 |
| Patel, VB | 1 |
| Mistry, N | 1 |
| Patni, N | 1 |
| Nandania, J | 1 |
| Balaraman, R | 1 |
1 other study available for felodipine and Cardiomyopathies
| Article | Year |
|---|---|
Doxorubicin mediated cardiotoxicity in rats: protective role of felodipine on cardiac indices.
Topics: Adenosine Triphosphatases; Animals; Antibiotics, Antineoplastic; Antihypertensive Agents; Antioxidan | 2013 |